Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia. - Jiang, Hao; Liu, Xiao-Hong; Kong, Jun; Wang, Jing; Jia, Jin-Song; Lu, Sheng-Ye; Gong, Li-Zhong; Zhao, Xiao-Su; Jiang, Qian; Chang, Ying-Jun; Wang, Yu; Ruan, Guo-Rui; et al. (Leukemia & Lymphoma, 2021)